These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14651214)

  • 1. Maintained salivary function after brachytherapy in patients with head and neck carcinomas--evaluation using quantitative salivary gland scintigraphy.
    Murata Y; Zhang L; Ishida R; Aung W; Taura S; Hossain M; Yoshimura R; Hoshina M; Akaike H; Sugaya T; Shibuya H
    Acta Oncol; 2002; 41(7-8):684-8. PubMed ID: 14651214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintained Salivary Function after Brachytherapy in Patients with Head and Neck Carcinomas - Evaluation Using Quantitative Salivary Gland Scintigraphy.
    Murata Y; Zhang L; Ishida R; Aung W; Taura SI; Hossain M; Yoshimura RI; Hoshina M; Akaike H; Sugaya T; Shibuya H
    Acta Oncol; 2002; 41(7-8):684-688. PubMed ID: 28758864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer.
    Tenhunen M; Collan J; Kouri M; Kangasmäki A; Heikkonen J; Kairemo K; Mäkitie A; Joensuu H; Saarilahti K
    Radiother Oncol; 2008 May; 87(2):260-7. PubMed ID: 18329118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands.
    Kapanen M; Collan J; Saarilahti K; Heikkonen J; Kairemo K; Tenhunen M
    Radiother Oncol; 2009 Oct; 93(1):109-14. PubMed ID: 19435641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
    Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands.
    Valdés Olmos RA; Keus RB; Takes RP; van Tinteren H; Baris G; Hilgers FJ; Hoefnagel CA; Balm AJ
    Cancer; 1994 Jun; 73(12):2886-93. PubMed ID: 8199984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours.
    Liem IH; Olmos RA; Balm AJ; Keus RB; van Tinteren H; Takes RP; Muller SH; Bruce AM; Hoefnagel CA; Hilgers FJ
    Eur J Nucl Med; 1996 Nov; 23(11):1485-90. PubMed ID: 8854847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era.
    Lee SW; Kang KW; Wu HG
    Head Neck; 2016 Apr; 38 Suppl 1():E1746-55. PubMed ID: 26875880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11C-methionine PET, a novel method for measuring regional salivary gland function after radiotherapy of head and neck cancer.
    Buus S; Grau C; Munk OL; Bender D; Jensen K; Keiding S
    Radiother Oncol; 2004 Dec; 73(3):289-96. PubMed ID: 15588873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of submandibular gland excision on salivary gland function in head and neck cancer patients.
    Jaguar GC; Lima EN; Kowalski LP; Pellizon AC; Carvalho AL; Alves FA
    Oral Oncol; 2010 May; 46(5):349-54. PubMed ID: 20227906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Botulinum Toxin to Preserve Gland Function after Radiotherapy in Patients with Head and Neck Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blinded Phase I Clinical Trial.
    Teymoortash A; Pfestroff A; Wittig A; Franke N; Hoch S; Harnisch S; Schade-Brittinger C; Hoeffken H; Engenhart-Cabillic R; Brugger M; Strauch K
    PLoS One; 2016; 11(3):e0151316. PubMed ID: 26991494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary gland-sparing helical tomotherapy for head and neck cancer: Preserved salivary function on quantitative salivary gland scintigraphy after tomotherapy.
    Kreps S; Berges O; Belin L; Zefkili S; Petras S; Giraud P
    Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Sep; 133(4):257-62. PubMed ID: 27291482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic imaging of the salivary glands in patients undergoing radiotherapy of head and neck neoplasms].
    Cardello P; Trinci M; Messineo D; Tuccimei M; Massa R; Marini M; Trinci M
    Radiol Med; 1998 Mar; 95(3):224-31. PubMed ID: 9638170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional scintigraphy of salivary glands of the head during telecobalt radiotherapy].
    Cha IH; Ritzl F
    Strahlentherapie; 1983 Nov; 159(11):690-4. PubMed ID: 6658857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative salivary gland scintigraphy in head and neck cancer patients following radiotherapy].
    Jiménez-Heffernan A; Gómez-Millán J; Sánchez De Mora E; Delgado Moreno J; Delgado Gil MM; Salgado C; Contreras Puertas P; Bermúdez Morales MC; López J; Paz Expósito J
    Rev Esp Med Nucl; 2010; 29(4):165-71. PubMed ID: 20462671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.